Highlight of 2023: Unlocking the therapeutic potential of natural killer cells—advances in adaptive functions, cellular engineering and immunotherapy
Immunology & Cell Biology · 2024
DOI: 10.1111/imcb.12769 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology & Cell Biology, 2024. Verfasst von Pui Yeng Lam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia. Hauptthemen laut MEDLINE: Cell Engineering, Immunotherapy, Killer Cells, Natural, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: US Department of Defense - Breast Cancer Research Program - Breakthrough Award Level 1, Medical Research Future Fund, Metro South Health Research Support Scheme.
Abstract (Originalsprache)
Natural killer (NK) cells possess potent cytotoxicity against infected and cancerous cells and hold promise in the development of new immunotherapies. This article for the Highlights of 2023 Series focuses on current advances in NK cell biology in cancerous and infectious settings and highlights opportunities for therapeutic interventions, including engineered NK cell therapies and advancements in feeder cell technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
Förderung
- US Department of Defense - Breast Cancer Research Program - Breakthrough Award Level 1
- Medical Research Future Fund
- Metro South Health Research Support Scheme
Zitieren
APA
Lam, P. Y., & Souza-Fonseca-Guimaraes, F. (2024). Highlight of 2023: Unlocking the therapeutic potential of natural killer cells—advances in adaptive functions, cellular engineering and immunotherapy. Immunology & Cell Biology. https://doi.org/10.1111/imcb.12769
Vancouver
Lam PY, Souza-Fonseca-Guimaraes F. Highlight of 2023: Unlocking the therapeutic potential of natural killer cells—advances in adaptive functions, cellular engineering and immunotherapy. Immunology & Cell Biology. 2024. doi:10.1111/imcb.12769
BibTeX
@article{Lam2024,
author = {Lam, Pui Yeng and Souza-Fonseca-Guimaraes, Fernando},
title = {Highlight of 2023: Unlocking the therapeutic potential of natural killer cells—advances in adaptive functions, cellular engineering and immunotherapy},
journal = {Immunology & Cell Biology},
year = {2024},
doi = {10.1111/imcb.12769}
}
EUVIMED